Production (Stage)
Pharvaris N.V.
PHVS
$16.78
$0.734.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.90% | 11.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.64% | 15.35% | |||
| Operating Income | 7.64% | -15.35% | |||
| Income Before Tax | -35.58% | 21.64% | |||
| Income Tax Expenses | -75.89% | 422.09% | |||
| Earnings from Continuing Operations | -31.61% | 19.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.61% | 19.19% | |||
| EBIT | 7.64% | -15.35% | |||
| EBITDA | 7.66% | -15.32% | |||
| EPS Basic | -31.21% | 19.57% | |||
| Normalized Basic EPS | -35.17% | 22.01% | |||
| EPS Diluted | -31.21% | 19.57% | |||
| Normalized Diluted EPS | -35.17% | 22.01% | |||
| Average Basic Shares Outstanding | 0.30% | 0.47% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||